Article info

Download PDFPDF

Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial

Authors

  1. a +49 30 450 564621 Ulrich.Keilholz{at}charite.de
  2. b mehnerja{at}cinj.rutgers.edu
  3. c Sebastian.Bauer{at}uk-essen.de
  4. d h.bourgeois{at}cjb72.org
  5. e mpatel{at}flcancer.com
  6. f dspg{at}bmhcc.org
  7. g john.nemunaitis{at}utoledo.edu
  8. h taylmatt{at}ohsu.edu
  9. i lwyrwicz{at}coi.pl lucjanwyrwicz{at}gmail.com
  10. j hmodoctor{at}hanmail.net hmodoctor{at}snubh.org
  11. k vijay.kasturi{at}emdserono.com
  12. l kevin.chin{at}emdserono.com
  13. m Anja.von.Heydebreck{at}merckgroup.com
  14. n gulleyj{at}mail.nih.gov
View Full Text

Citation

Keilholz U, Mehnert JM, Bauer S, et al
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial

Publication history

  • Received July 19, 2018
  • Accepted November 20, 2018
  • First published January 16, 2019.
Online issue publication 
January 16, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.